State NJ
Clinical Trials in New Jersey
New Jersey is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Jersey and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 237 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 237. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT06099769 Phase 2
Recruiting
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemo...
Condition
Metastatic Breast Cancer
Enrollment
201 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06312124 N/A
Recruiting
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Condition
Surgery
Enrollment
266 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06318169 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Enrollment
1,350 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT06129903 N/A
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Q...
Condition
Sarcoma
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06174727 N/A
Recruiting
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Condition
Intracranial Aneurysm
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Montefiore Medical Center
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT05671510 Phase 3
Recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhib...
Condition
Non Small Cell Lung Cancer
Enrollment
630 pts
Location
United States, Australia, Belgium
Sponsor
OncoC4, Inc.
NCT06208150 Phase 3
Recruiting
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, a...
Condition
Multiple Myeloma
Enrollment
795 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06765317 Phase 2
Recruiting
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lympho...
Condition
Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
42 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05790668 N/A
Recruiting
Motivational Refinements for Facilitating Reinforcement Schedule Thinning
Condition
Decreasing Destructive Behavior
Enrollment
30 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05787574 Phase 2
Recruiting
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With ...
Condition
Primary Immune Regulatory Disorder
Enrollment
39 pts
Location
United States
Sponsor
Joseph Oved
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
NCT07080242 Phase 1
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell L...
Condition
Small Cell Lung Cancer Metastatic or Locally Advanced
Enrollment
120 pts
Location
United States
Sponsor
SystImmune Inc.
NCT07227597 Phase 1, Phase 2
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in ...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
170 pts
Location
United States, Argentina, Chile
Sponsor
Merck Sharp & Dohme LLC
NCT05766280 N/A
Recruiting
Internet Assisted Career-Oriented Soft-skills Training for Transition Age Youth ...
Condition
Mental Health Wellness 1
Enrollment
126 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT03096197 N/A
Recruiting
Exoskeleton and Spinal Cord Stimulation for SCI
Condition
Spinal Cord Injury
Enrollment
24 pts
Location
United States
Sponsor
Kessler Foundation
NCT06411626 N/A
Recruiting
Home Reported Outcomes in PNH
Condition
Paroxysmal Nocturnal Hemoglobinuria
Enrollment
128 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
NCT03922893 N/A
Recruiting
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for He...
Condition
Cancer
Enrollment
1,500 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07471048 N/A
Recruiting
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on I...
Condition
Psoriasis
Enrollment
100 pts
Location
United States
Sponsor
Sirt3 LLC
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06246968 Phase 1
Recruiting
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Condition
Metastatic Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06255925 N/A
Recruiting
A Strength-Based Employment Maintenance Program for Individuals on the Autism Sp...
Condition
Autism
Enrollment
30 pts
Location
United States
Sponsor
Kessler Foundation
NCT06846320 Phase 2
Recruiting
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932...
Condition
Generalized Anxiety Disorder (GAD)
Enrollment
315 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology